Your browser is no longer supported. Please, upgrade your browser.
KURE [NYSE]
KraneShares MSCI All China Health Care Index ETF
Index- P/E- EPS (ttm)- Insider Own- Shs Outstand- Perf Week-5.30%
Market Cap- Forward P/E- EPS next Y- Insider Trans- Shs Float- Perf Month-11.05%
Income- PEG- EPS next Q- Inst Own- Short Float- Perf Quarter13.44%
Sales- P/S- EPS this Y- Inst Trans- Short Ratio- Perf Half Y7.77%
Book/sh- P/B- EPS next Y- ROA- Target Price- Perf Year46.05%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range20.15 - 47.69 Perf YTD-1.64%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-19.46% Beta-
Dividend %- Quick Ratio- Sales past 5Y- Gross Margin- 52W Low90.62% ATR1.29
Employees- Current Ratio- Sales Q/Q- Oper. Margin- RSI (14)33.61 Volatility1.92% 1.72%
OptionableNo Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume1.89 Prev Close40.50
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume110.09K Price38.41
Recom- SMA20-12.25% SMA50-8.15% SMA2008.22% Volume207,713 Change-5.16%
Feb-16-21 01:41PM  
Feb-04-21 01:25PM  
Nov-11-20 01:12PM  
Sep-24-20 04:00AM  
Aug-25-20 09:00AM  
Jun-22-20 11:00AM  
Jun-15-20 08:18AM  
May-15-20 07:40AM  
Mar-31-20 08:00AM  
Jan-24-20 01:33PM  
Oct-28-19 08:40AM  
Oct-23-19 08:00AM  
Mar-05-19 01:30PM  
Dec-18-18 12:01PM  
Nov-16-18 11:40AM  
Oct-24-18 12:27PM  
Oct-22-18 01:57PM  
Sep-06-18 12:21PM  
12:14PM  
Sep-05-18 08:30AM  
Aug-20-18 03:20PM  
Aug-16-18 12:25PM  
11:49AM  
Feb-16-18 09:49AM  
Feb-07-18 08:00AM  
Feb-02-18 08:30AM  
Feb-01-18 01:53PM  
The investment seeks to provide investment results that, before fees and expenses, track the price and yield performance of the MSCI China All Shares Health Care 10/40 Index (the "underlying index"). The fund will invest at least 80% of its total assets in components of the underlying index, depositary receipts, including American depositary receipts, representing such components and securities underlying depositary receipts in the underlying index. The underlying index is a free float adjusted market capitalization weighted index designed to track the equity market performance of Chinese companies engaged in the healthcare sector. The fund is non-diversified.